China SXT Pharmaceuticals Statistics
Total Valuation
SXTC has a market cap or net worth of $31.52 million. The enterprise value is $22.88 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
SXTC has 13.76 million shares outstanding. The number of shares has increased by 378.48% in one year.
Current Share Class | 13.76M |
Shares Outstanding | 13.76M |
Shares Change (YoY) | +378.48% |
Shares Change (QoQ) | +161.99% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 0.01% |
Float | 13.76M |
Valuation Ratios
The trailing PE ratio is 0.11.
PE Ratio | 0.11 |
Forward PE | n/a |
PS Ratio | 0.35 |
Forward PS | n/a |
PB Ratio | 0.07 |
P/TBV Ratio | 2.10 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 3.95 |
EV / Sales | 12.58 |
EV / EBITDA | 3.37 |
EV / EBIT | 3.46 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.66.
Current Ratio | 1.40 |
Quick Ratio | 1.28 |
Debt / Equity | 0.66 |
Debt / EBITDA | 1.44 |
Debt / FCF | n/a |
Interest Coverage | 16.57 |
Financial Efficiency
Return on equity (ROE) is 57.63% and return on invested capital (ROIC) is 24.65%.
Return on Equity (ROE) | 57.63% |
Return on Assets (ROA) | 18.15% |
Return on Invested Capital (ROIC) | 24.65% |
Return on Capital Employed (ROCE) | 43.16% |
Revenue Per Employee | $24,245 |
Profits Per Employee | $77,267 |
Employee Count | 75 |
Asset Turnover | 0.08 |
Inventory Turnover | 1.31 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.25% in the last 52 weeks. The beta is 1.04, so SXTC's price volatility has been similar to the market average.
Beta (5Y) | 1.04 |
52-Week Price Change | -73.25% |
50-Day Moving Average | 3.02 |
200-Day Moving Average | 4.55 |
Relative Strength Index (RSI) | 49.51 |
Average Volume (20 Days) | 10,560,284 |
Short Selling Information
Short Interest | 51,288 |
Short Previous Month | 52,671 |
Short % of Shares Out | 0.37% |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.36 |
Income Statement
In the last 12 months, SXTC had revenue of $1.82 million and earned $5.80 million in profits. Earnings per share was $20.77.
Revenue | 1.82M |
Gross Profit | 400,384 |
Operating Income | 6.62M |
Pretax Income | -14.14M |
Net Income | 5.80M |
EBITDA | 6.79M |
EBIT | 6.62M |
Earnings Per Share (EPS) | $20.77 |
Full Income Statement Balance Sheet
The company has $18.51 million in cash and $9.87 million in debt, giving a net cash position of $8.64 million or $0.63 per share.
Cash & Cash Equivalents | 18.51M |
Total Debt | 9.87M |
Net Cash | 8.64M |
Net Cash Per Share | $0.63 |
Equity (Book Value) | 15.03M |
Book Value Per Share | 30.79 |
Working Capital | 6.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.71 million and capital expenditures -$7,063, giving a free cash flow of -$2.71 million.
Operating Cash Flow | -2.71M |
Capital Expenditures | -7,063 |
Free Cash Flow | -2.71M |
FCF Per Share | -$0.20 |
Full Cash Flow Statement Margins
Gross margin is 22.02%, with operating and profit margins of 363.97% and 318.69%.
Gross Margin | 22.02% |
Operating Margin | 363.97% |
Pretax Margin | 318.69% |
Profit Margin | 318.69% |
EBITDA Margin | 373.27% |
EBIT Margin | 363.97% |
FCF Margin | n/a |